The Journal of Internal Korean Medicine (대한한방내과학회지)

The Society of Internal Korean Medicine (대한한방내과학회)
권호 표지

Effects of Chunglijagam-tang Aqueous Extracts on Streptozotocin-induced Rat Diabetes and Related Complications

청리자감탕이 Streptozotocin으로 유발(誘發)된 흰쥐의 당뇨병(糖尿病) 및 당뇨병합병증(糖尿病合倂症)에 미치는 영향

  • Park, Yoon-Sik (Dept. of Oriental Internal Medicine, College of Oriental Medicine, Daegu Haany University) ;
  • Yoon, Gyeong-Min (Dept. of Oriental Internal Medicine, College of Oriental Medicine, Daegu Haany University) ;
  • Im, Eun-Yeong (Dept. of Oriental Internal Medicine, College of Oriental Medicine, Daegu Haany University) ;
  • Shin, Hyeon-Chul (Dept. of Oriental Internal Medicine, College of Oriental Medicine, Daegu Haany University) ;
  • Kang, Seok-Bong (Dept. of Oriental Internal Medicine, College of Oriental Medicine, Daegu Haany University)
  • 박윤식 (대구한의대학교 한의과대학 신계내과학교실) ;
  • 윤경민 (대구한의대학교 한의과대학 신계내과학교실) ;
  • 임은영 (대구한의대학교 한의과대학 신계내과학교실) ;
  • 신현철 (대구한의대학교 한의과대학 신계내과학교실) ;
  • 강석봉 (대구한의대학교 한의과대학 신계내과학교실)
  • Published : 2010.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objective : The object of this study was to observe the effects of aqueous extracts of Chunglijagam-tang(CLJGT), which has traditionally been used in Korean medicine for treating various diseases, on streptozotocin(STZ)-induced rat diabetes and related complications: diabetic nephropathy, hepatopathy and hyperlipemia. Methods : CLJGT extracts were orally administered once a day for 28 days at a dosage 50, 100 and 200mg/kg from 21 days after STZ treatment, and the changes on body weights, blood glucose levels, kidney and liver weights, serum BUN(blood urea nitrogen), creatinine, AST(aspartate transaminase), ALT(alanine aminotransferase), HDL(high-density lipoprotein), LDL (low-density lipoprotein), total cholesterol and triglyceride levels were observed with pancreatic malondialdehyde(MDA) and glutathione(GSH) contents. The results were compared with silymarin 100mg/kg. Results : Significant decrease of blood glucose levels, kidney and liver weights, serum BUN, creatinine, AST, ALT, LDL, total cholesterol, triglyceride levels, pancreatic malondialdehyde contents and significant increase of body weights, serum HDL levels, pancreatic glutathione contents were detected in CLJGT extracts 50, 100 and 200mg/kg administered groups as compared to the STZ control group. Conclusion : CLJGT extracts showed favorable effects on the STZ-induced diabetes and related complications mediated by their antioxidant effects as similar to silymarin. Therefore, it is expected that DBEH has potential for use in the management of diabetes and various diabetic complications.

Keywords

References

  1. 두호경. 동의신계학. 서울: 동양의학연구원; 1993, p. 1173-8.
  2. 2009.3.13. 보건복지부. 2007년도 보건복지통계연보. 2007. Available at http://www.mohw.go.kr /user.tdf?a=user.tbdata.BoardApp&c=2001&bo ard_id=gp_tb_data&skin=p_new_m2_co mmon&bunr_code=310&mc=P_03_05_02
  3. E Braunwald, A Fauci, D. Kasper, S. Hauser, D. Longo, J. Jameson. 해리슨 내과학. 15th. 서울: MIP; 2003, p. 2178-9, 2188.
  4. 朱震亨. 丹溪心法. 서울: 대성문화사; 1982, p. 503-9.
  5. 공정현. 만병회춘, 香港: 인민위생출판사; 1980, p. 201.
  6. 林偑琴. 類證治裁, 北京: 의풍 族風文化社; 1985, p. 77, 1839.
  7. 許浚. 標點,索引東醫寶鑑. 東醫文獻硏究室再編輯. 서울: 法仁文化社; 2005, p. 337.
  8. 심범상, 강희, 김성훈, 안규석. 淸離滋坎湯에 의한 면역기능 연구. 동의병리학회지. 2001;15:693-6.
  9. 조경삼, 김시영, 박재경, 최성훈, 정세영, 윤희중. 複合韓藥劑淸籬滋坎湯의 抗癌效果및 作用機轉糾明. 경희대학교 동서의학연구소 국제학술대회 논문집. 1999:231-43.
  10. Institute of Laboratory Animal Resources (Commission on Life Sciences, National Research Council, USA). Guide for the care and use of laboratory animals. 7. Washington, D.C.: National Academic press; 1996, p. 1-118.
  11. Kavutcu M, Canbolat O, Oztürk S, Olcay E, Ulutepe S, Ekinci C, Gökhun IH, Durak I. Reduced enzymatic antioxidant defense mechanism in kidney tissues from gentamicin-treated guinea pigs: effects of vitamins E and C. Nephron. 1996;72:269-74. https://doi.org/10.1159/000188853
  12. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-75.
  13. Draper HH, Hadley M. Methods in Enzymology. New York: Academic Press; 1900, p. 421.
  14. Eyer P, Podhradsky D. Evaluation of the micromethod for determination of glutathione using enzymatic cycling and Ellman's reagent. Anal Biochem. 1986;153:57-66. https://doi.org/10.1016/0003-2697(86)90061-8
  15. Quine SD, Raghu PS. Effects of (-)-epicatechin, a flavonoid on lipid peroxidation and antioxidants in STZ-induced diabetic liver, kidney and heart. Pharmacol Rep. 2005;57:610-5.
  16. Wellington K, Jarvis B. Silymarin: a review of its clinical properties in the management of hepatic disorders. BioDrugs. 2001;15:465-89. https://doi.org/10.2165/00063030-200115070-00005
  17. Lorenz D, Mennicke WH. Elimination of drugs in cholecystectomized patients. Studies with silymarin in patients with extrahepatic complications. Methods Find Exp Clin Pharmacol. 1981;3: 103-6.
  18. Velussi M, Cernigoi AM, De Monte A, Dapas F, Caffau C, Zilli M. Long-term(12 months) treatment with an anti-oxidant drug(silymarin) is effective on hyperinsulinemia, exogenous insulin need and malondialdehyde levels in cirrhotic diabetic patients. J Hepatol. 1997;26:871-9. https://doi.org/10.1016/S0168-8278(97)80255-3
  19. Saller R, Meier R, Brignoli R. The use of silymarin in the treatment of liver diseases. Drugs. 2001 ;61:2035-63. https://doi.org/10.2165/00003495-200161140-00003
  20. Lirussi F, Beccarello A, Zanette G, De Monte A, Donadon V, Velussi M, Crepaldi G. Silybin -beta-cyclodextrin in the treatment of patients with diabetes mellitus and alcoholic liver disease. Efficacy study of a new preparation of an anti-oxidant agent. Diabetes Nutr Metab. 2002;15:222-31.
  21. Huseini HF, Larijani B, Heshmat R, Fakhrzadeh H, Radjabipour B, Toliat T, Raza M. The efficacy of Silybum marianum(L.) Gaertn. (silymarin) in the treatment of type II diabetes: a randomized, double-blind, placebo-controlled, clinical trial. Phytother Res. 2006;20:1036-9. https://doi.org/10.1002/ptr.1988
  22. Guerrero-Analco JA, Hersch-Martinez P, Pedraza -Chaverri J, Navarrete A, Mata R. Antihyperglycemic effect of constituents from Hintonia standleyana in STZ-induced diabetic rats. Planta Med. 2005 ;71:1099-105. https://doi.org/10.1055/s-2005-873137
  23. Uchiyama S, Yamaguchi M. Oral administration of beta-cryptoxanthin prevents bone loss in STZ-diabetic rats in vivo. Biol Pharm Bull. 2005;28:1766-9. https://doi.org/10.1248/bpb.28.1766
  24. Cohen MP, Clements RS, Cohen JA, Shearman CW. Prevention of decline in renal function in the diabetic db/db mouse. Diabetologia. 1996 ;39:270-4. https://doi.org/10.1007/BF00418341
  25. Trachtman H, Futterweit S, Pine E, Mann J, Valderrama E. Chronic diabetic nephropathy: role of inducible nitric oxide synthase. Pediatr Nephrol. 2002;17:20-9. https://doi.org/10.1007/s004670200004
  26. Montilla P, Barcos M, Munoz MC, Bujalance I, Munoz-Castaneda JR, Tunez I. Red wine prevents brain oxidative stress and nephropathy in STZ-induced diabetic rats. J Biochem Mol Biol. 2005;38:539-44. https://doi.org/10.5483/BMBRep.2005.38.5.539
  27. Sato S, Yamate J, Hori Y, Hatai A, Nozawa M, Sagai M. Protective effect of polyphenol-polyphenolcontaining azuki bean(Vigna angularis) seed coats on the renal cortex in STZ-induced diabetic rats. J Nutr Biochem. 2005;16:547-53. https://doi.org/10.1016/j.jnutbio.2005.02.003
  28. Sodikoff CH. Laboratory profiles of small animal diseases. A guide to laboratory diagnosis. 2nd ed., St. Louise: Mosby; 1995, p. 1-36.
  29. Imaeda A, Kaneko T, Aoki T, Kondo Y, Nakamura N, Nagase H, Yoshikawa T. Antioxidative effects of fluvastatin and its metabolites against DNA damage in STZtreated mice. Food Chem Toxicol. 2002;40 :1415-22. https://doi.org/10.1016/S0278-6915(02)00111-4
  30. Clark TA, Heyliger CE, Edel AL, Goel DP, Pierce GN. Codelivery of a tea extract prevents morbidity and mortality associated with oral vanadate therapy in STZ-induced diabetic rats. Metabolism. 2004;53:1145-51. https://doi.org/10.1016/j.metabol.2004.03.017
  31. Ducobu J. Dyslipidaemia and diabetes mellitus. Rev Med Liege. 2005;60:578-85.
  32. Bhandari U, Kanojia R, Pillai KK. Effect of ethanolic extract of Zingiber officinale on dyslipidaemia in diabetic rats. J Ethnopharmacol. 2005;97:227-30. https://doi.org/10.1016/j.jep.2004.11.011
  33. Milionis HJ, Kakafika AI, Tsouli SG, Athyros VG, Bairaktari ET, Seferiadis KI, Elisaf MS. Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia. Am Heart J. 2004;148:635-40. https://doi.org/10.1016/j.ahj.2004.04.005
  34. Forrester JS, Makkar R, Shah PK. Increasing high-density lipoprotein cholesterol in dyslipidemia by cholesteryl ester transfer protein inhibition: an update for clinicians. Circulation. 2005;111 :1847-54. https://doi.org/10.1161/01.CIR.0000160860.36911.BD
  35. Kamada T, Hata J, Kusunoki H, Ito M, Tanaka S, Kawamura Y, Chayama K, Haruma K. Eradication of Helicobacter pylori increases the incidence of hyperlipidaemia and obesity in peptic ulcer patients. Dig Liver Dis. 2005;37 :39-43. https://doi.org/10.1016/j.dld.2004.07.017
  36. Cheng JW. Rosuvastatin in the management of hyperlipidemia. Clin Ther. 2004;26:1368-87. https://doi.org/10.1016/j.clinthera.2004.09.005
  37. Pirat B, Korkmaz ME, Eroglu S, Tayfun E, Yildirir A, Ulucam M, Ozin B, Muderrisoglu H. The effects of simvastatin combined with different antioxidant vitamin regimens on serum lipid profile in patients with low HDL cholesterol levels. Anadolu Kardiyol Derg. 2004;4:318-22.
  38. Zdrenghea D, Gligor E, Ossian V, Pop D. The effect of simvastatin associated with ranitidine and alcohol upon serum lipids. Rom J Intern Med. 2004;42:143-8.
  39. Garg MC, Singh KP, Bansal DD. Effect of vitamin C supplementation on oxidative stress in experimental diabetes. Indian J Exp Biol. 1997;35:264-6.
  40. Collier A, Wilson R, Bradley H, Thomson JA, Small M. Free radical activity in type 2 diabetes. Diabet Med. 1990;7:27-30. https://doi.org/10.1111/j.1464-5491.1990.tb01302.x
  41. Ceriello A, Quatraro A, Giugliano D. New insights on non-enzymatic glycosylation may lead to therapeutic approaches for the prevention of diabetic complications. Diabet Med. 1992;9:297-9. https://doi.org/10.1111/j.1464-5491.1992.tb01783.x
  42. Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care. 1996;19:257-67. https://doi.org/10.2337/diacare.19.3.257